Resilient Biotics, Inc. — Form D/A
Resilient Biotics, Inc. of RESEARCH TRIANGLE PARK, NC, a company, filed a Form D amendment with the SEC on 2024-12-12. The offering totals $4.6M, of which $3.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-12-12
- Form: D/A
- Accession: 0001836461-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.6M
- Amount sold: $3.9M
- Remaining: $738K
- Investors: 6
- Date of first sale: 2022-08-16
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-456342
Issuer
- Name: Resilient Biotics, Inc.
- CIK: 0001836461
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 2 DAVIS DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Phone: 717-350-3133
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Christopher Belnap | Director | Durham, NC |
| Eric Eason | Director | Durham, NC |
| Rachelle Galvin | Director | Durham, NC |
| Drew Lanza | Director | Durham, NC |
| John Peryam | Director | Shawnee, KS |
| Christopher Belnap | Executive Officer | Durham, NC |
| Rachelle Galvin | Executive Officer | Durham, NC |
| Greg Werner | Director | Durham, NC |
| Greg Werner | Executive Officer | Durham, NC |
Other filings by this issuer (3)
More